Skip to main content
Delfa

← All trials/NCT07623148

Recruiting

GLP-1 RA Cessation and Gastric Ultrasound Findings

Time-dependent Association Between Cessation of Glucagon-like Peptide-1 Receptor Agonists and Residual Gastric Contents Assessed by Point-of-care Gastric Ultrasound: a Prospective Observational Study

Asset

GLP-1 / incretin class catch-all

Listed sites

1

Recruiting sites

1

Estimated enrollment

186

Study population

Obesity / overweight

Eligibility highlights

-

Primary endpoint

•Estimated Gastric Volume Normalized to Body Weight

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT07623148
Org study IDWonkwang UH25

Timeline

Milestones

Study first posted2026-06-03actual
Study start2026-07-01actual
Last update posted2026-07-06actual
Primary completion2026-07-27estimated
Study completion2026-08-20estimated

Assets

Investigational agents

GLP-1 / incretin class catch-all

Who this study enrolls

Obesity / overweight

Who can enroll

Minimum age19 Years
Maximum age65 Years
SexAll
Sampling methodNon probability sample

Study population text

Adult patients receiving glucagon-like peptide-1 receptor agonists who are scheduled for elective non-cardiac surgery requiring general anesthesia at a tertiary academic hospital. Participants will be screened consecutively by the perioperative anesthesia team and enrolled if eligibility criteria are met.

Inclusion criteria

•Adults aged 18 years or older.
•Patients receiving a glucagon-like peptide-1 receptor agonist.
•Patients scheduled for elective non-cardiac surgery requiring general anesthesia.
•Patients able to provide written informed consent.

Exclusion criteria

•Emergency surgery.
•History of prior gastric surgery.
•Known gastroparesis or severe gastroesophageal reflux disease.
•Declined or unable to provide written informed consent.

Endpoints (4)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Other (unclassified)
2
Weight & body composition
1
Patient-reported / QoL
1

Weight & body composition

1 endpoint
Primary/protocol endpoint

Estimated Gastric Volume Normalized to Body Weight

Time frame:Immediately before induction of anesthesia on the day of surgery

descriptive

Patient-reported / QoL

1 endpoint
Secondary/protocol endpoint

Gastrointestinal Symptom Score

Time frame:Within 24 hours before surgery

descriptive

Other (unclassified)

2 endpoints
Secondary/protocol endpoint/low confidence

Antral Cross-Sectional Area

Time frame:Immediately before induction of anesthesia on the day of surgery

descriptive

Secondary/protocol endpoint/low confidence

Perlas Gastric Ultrasound Grade

Time frame:Immediately before induction of anesthesia on the day of surgery

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 6, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.